Jennewein Biotechnologie

company

About

Jennewein Biotechnologie is a science-based company in the field of industrial biotechnology.

  • 11 - 50

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
€15M
Industries
Biotechnology,Medical
Founded date
Jan 1, 2005
Number Of Employee
11 - 50
Operating Status
Active

Jennewein Biotechnologie is a science-based company in the field of industrial biotechnology. They specialize in the development of new processes for the identification, characterization and production of scarce, functional monosaccharides and oligosaccharides. Their main focus is the production of sugar molecules with attractive health benefits.

Human milk oligosaccharides (HMOs) represent one of their major fields of activity. These complex natural sugar molecules are found uniquely in human milk. Human milk oligosaccharides cannot be digested by humans and thus, do not provide calories. However, HMOs have various functional health benefits beyond the intake of calories. They have developed innovative processes for the production of HMOs and have built up production capacity over the last few years allowing us to supply these oligosaccharides as food ingredients.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€15M
Jennewein Biotechnologie has raised a total of €15M in funding over 2 rounds. Their latest funding was raised on Jul 25, 2018 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 25, 2018 Debt Financing €15M 1 European Investment Bank Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Jennewein Biotechnologie is funded by 1 investors. European Investment Bank are the most recent investors.
Investor Name Lead Investor Funding Round
European Investment Bank Yes Debt Financing